EMEA (Europe, Middle East and Africa) Over-The-Counter (OTC) Drugs Market Report 2017

October 2017 | 111 pages | ID: E03BF2B0972PEN
QYResearch

Abstracts

In this report, the EMEA Over-The-Counter (OTC) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
%li%Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Over-The-Counter (OTC) Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Over-The-Counter (OTC) Drugs market competition by top manufacturers/players, with Over-The-Counter (OTC) Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bayer
• Boehringer Ingelheim
• GSK
• Novartis
• Pfizer
• PGT healthcare
• Sanofi
• Teva Pharmaceuticals
• Takeda
• Cipla
• Sun Pharmaceutical Industries
• Glenmark
• Innovus Pharmaceuticals

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Cold and Flu Products
• Analgesics
• Dermatological Products
• Gastrointestinal Products
• Vitamin
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Over-The-Counter (OTC) Drugs for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Over-The-Counter (OTC) Drugs Market Report 2017

1 OVER-THE-COUNTER (OTC) DRUGS OVERVIEW

1.1 Product Overview and Scope of Over-The-Counter (OTC) Drugs
1.2 Classification of Over-The-Counter (OTC) Drugs
  1.2.1 EMEA Over-The-Counter (OTC) Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Over-The-Counter (OTC) Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Cold and Flu Products
  1.2.4 Analgesics
  1.2.5 Dermatological Products
  1.2.6 Gastrointestinal Products
  1.2.7 Vitamin
  1.2.8 Other
1.3 EMEA Over-The-Counter (OTC) Drugs Market by Application/End Users
  1.3.1 EMEA Over-The-Counter (OTC) Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 EMEA Over-The-Counter (OTC) Drugs Market by Region
  1.4.1 EMEA Over-The-Counter (OTC) Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Over-The-Counter (OTC) Drugs (2012-2022)
  1.5.1 EMEA Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2012-2022)

2 EMEA OVER-THE-COUNTER (OTC) DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Over-The-Counter (OTC) Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Over-The-Counter (OTC) Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Over-The-Counter (OTC) Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Over-The-Counter (OTC) Drugs Sale Price by Players (2012-2017)
2.2 EMEA Over-The-Counter (OTC) Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Over-The-Counter (OTC) Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Over-The-Counter (OTC) Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Over-The-Counter (OTC) Drugs Sale Price by Type (2012-2017)
2.3 EMEA Over-The-Counter (OTC) Drugs (Volume) by Application
2.4 EMEA Over-The-Counter (OTC) Drugs (Volume and Value) by Region
  2.4.1 EMEA Over-The-Counter (OTC) Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Over-The-Counter (OTC) Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Over-The-Counter (OTC) Drugs Sales Price by Region (2012-2017)

3 EUROPE OVER-THE-COUNTER (OTC) DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Over-The-Counter (OTC) Drugs Sales and Value (2012-2017)
  3.1.1 Europe Over-The-Counter (OTC) Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Over-The-Counter (OTC) Drugs Sales and Market Share by Type
3.3 Europe Over-The-Counter (OTC) Drugs Sales and Market Share by Application
3.4 Europe Over-The-Counter (OTC) Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Over-The-Counter (OTC) Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Over-The-Counter (OTC) Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST OVER-THE-COUNTER (OTC) DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Over-The-Counter (OTC) Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Over-The-Counter (OTC) Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Over-The-Counter (OTC) Drugs Sales and Market Share by Type
4.3 Middle East Over-The-Counter (OTC) Drugs Sales and Market Share by Application
4.4 Middle East Over-The-Counter (OTC) Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Over-The-Counter (OTC) Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Over-The-Counter (OTC) Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)

5 AFRICA OVER-THE-COUNTER (OTC) DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Over-The-Counter (OTC) Drugs Sales and Value (2012-2017)
  5.1.1 Africa Over-The-Counter (OTC) Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Over-The-Counter (OTC) Drugs Sales and Market Share by Type
5.3 Africa Over-The-Counter (OTC) Drugs Sales and Market Share by Application
5.4 Africa Over-The-Counter (OTC) Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Over-The-Counter (OTC) Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Over-The-Counter (OTC) Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Over-The-Counter (OTC) Drugs Sales and Growth Rate (2012-2017)

6 EMEA OVER-THE-COUNTER (OTC) DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bayer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Boehringer Ingelheim
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GSK
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Novartis
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 PGT healthcare
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Takeda
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cipla
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Over-The-Counter (OTC) Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Sun Pharmaceutical Industries
6.12 Glenmark
6.13 Innovus Pharmaceuticals

7 OVER-THE-COUNTER (OTC) DRUGS MANUFACTURING COST ANALYSIS

7.1 Over-The-Counter (OTC) Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Over-The-Counter (OTC) Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Over-The-Counter (OTC) Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA OVER-THE-COUNTER (OTC) DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Over-The-Counter (OTC) Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Over-The-Counter (OTC) Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Over-The-Counter (OTC) Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Over-The-Counter (OTC) Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Over-The-Counter (OTC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Over-The-Counter (OTC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Over-The-Counter (OTC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Over-The-Counter (OTC) Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Over-The-Counter (OTC) Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Over-The-Counter (OTC) Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Over-The-Counter (OTC) Drugs
Figure EMEA Over-The-Counter (OTC) Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Cold and Flu Products Product Picture
Figure Analgesics Product Picture
Figure Dermatological Products Product Picture
Figure Gastrointestinal Products Product Picture
Figure Vitamin Product Picture
Figure Other Product Picture
Figure EMEA Over-The-Counter (OTC) Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Over-The-Counter (OTC) Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure EMEA Over-The-Counter (OTC) Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Over-The-Counter (OTC) Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Over-The-Counter (OTC) Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Over-The-Counter (OTC) Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Over-The-Counter (OTC) Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Sales Share by Players (2012-2017)
Figure 2016 Over-The-Counter (OTC) Drugs Sales Share by Players
Figure 2017 Over-The-Counter (OTC) Drugs Sales Share by Players
Figure EMEA Over-The-Counter (OTC) Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Over-The-Counter (OTC) Drugs Revenue Share by Players
Table 2017 EMEA Over-The-Counter (OTC) Drugs Revenue Share by Players
Table EMEA Over-The-Counter (OTC) Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Over-The-Counter (OTC) Drugs by Type (2012-2017)
Figure EMEA Over-The-Counter (OTC) Drugs Sales Market Share by Type (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Over-The-Counter (OTC) Drugs by Type in 2016
Table EMEA Over-The-Counter (OTC) Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Over-The-Counter (OTC) Drugs by Application (2012-2017)
Figure EMEA Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2016
Table EMEA Over-The-Counter (OTC) Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Over-The-Counter (OTC) Drugs by Region (2012-2017)
Figure EMEA Over-The-Counter (OTC) Drugs Sales Market Share in 2016
Table EMEA Over-The-Counter (OTC) Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Over-The-Counter (OTC) Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Over-The-Counter (OTC) Drugs by Region (2012-2017)
Figure EMEA Over-The-Counter (OTC) Drugs Revenue Market Share Regions in 2016
Table EMEA Over-The-Counter (OTC) Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2012-2017)
Table Europe Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2012-2017)
Table Europe Over-The-Counter (OTC) Drugs Market Share by Type (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Market Share by Type in 2016
Table Europe Over-The-Counter (OTC) Drugs Sales (K Units) by Application (2012-2017)
Table Europe Over-The-Counter (OTC) Drugs Market Share by Application (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Market Share by Application in 2016
Table Europe Over-The-Counter (OTC) Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Sales Market Share by Countries in 2016
Table Europe Over-The-Counter (OTC) Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Countries in 2016
Figure Germany Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Over-The-Counter (OTC) Drugs Market Share by Type (2012-2017)
Figure Middle East Over-The-Counter (OTC) Drugs Market Share by Type (2012-2017)
Table Middle East Over-The-Counter (OTC) Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Over-The-Counter (OTC) Drugs Market Share by Applications (2012-2017)
Figure Middle East Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2016
Table Middle East Over-The-Counter (OTC) Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Over-The-Counter (OTC) Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Over-The-Counter (OTC) Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Over-The-Counter (OTC) Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Over-The-Counter (OTC) Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2012-2017)
Table Africa Over-The-Counter (OTC) Drugs Sales Market Share by Type (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Sales Market Share by Type (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Sales Market Share by Type in 2016
Table Africa Over-The-Counter (OTC) Drugs Sales (K Units) by Application (2012-2017)
Table Africa Over-The-Counter (OTC) Drugs Sales Market Share by Application (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Sales Market Share by Application (2012-2017)
Table Africa Over-The-Counter (OTC) Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Sales Market Share by Countries in 2016
Table Africa Over-The-Counter (OTC) Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Countries in 2016
Figure South Africa Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Bayer Over-The-Counter (OTC) Drugs Basic Information List
Table Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Over-The-Counter (OTC) Drugs Basic Information List
Table Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table GSK Over-The-Counter (OTC) Drugs Basic Information List
Table GSK Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure GSK Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis Over-The-Counter (OTC) Drugs Basic Information List
Table Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Over-The-Counter (OTC) Drugs Basic Information List
Table Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table PGT healthcare Over-The-Counter (OTC) Drugs Basic Information List
Table PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure PGT healthcare Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure PGT healthcare Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi Over-The-Counter (OTC) Drugs Basic Information List
Table Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Basic Information List
Table Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Takeda Over-The-Counter (OTC) Drugs Basic Information List
Table Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Takeda Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Takeda Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Cipla Over-The-Counter (OTC) Drugs Basic Information List
Table Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Cipla Over-The-Counter (OTC) Drugs Sales Market Share in EMEA (2012-2017)
Figure Cipla Over-The-Counter (OTC) Drugs Revenue Market Share in EMEA (2012-2017)
Table Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Basic Information List
Table Glenmark Over-The-Counter (OTC) Drugs Basic Information List
Table Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Over-The-Counter (OTC) Drugs
Figure Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs
Figure Over-The-Counter (OTC) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Over-The-Counter (OTC) Drugs Major Manufacturers in 2016
Table Major Buyers of Over-The-Counter (OTC) Drugs
Table Distributors/Traders List
Figure EMEA Over-The-Counter (OTC) Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Over-The-Counter (OTC) Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Over-The-Counter (OTC) Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Over-The-Counter (OTC) Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Over-The-Counter (OTC) Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Over-The-Counter (OTC) Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Over-The-Counter (OTC) Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Over-The-Counter (OTC) Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Over-The-Counter (OTC) Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Over-The-Counter (OTC) Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Over-The-Counter (OTC) Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources